Target intelligence / Profile preview

NLR family apoptosis inhibitory protein pseudogene 3 (NAIPP3)

Target
NAIPP3
Molecular classification
Other (pseudogene)
01

Overview

NAIP pseudogene 3 (NAIPP3) is annotated as a **pseudogene** related to the NLR family apoptosis inhibitory protein (NAIP) gene cluster. Unlike the canonical "NLR family apoptosis inhibitory protein" (NAIP/BIRC1), which encodes a functional protein that suppresses apoptosis and participates in innate immune signaling, NAIPP3 does not produce a functional protein product due to truncations or deletions typical of pseudogenes. The human NAIP locus includes multiple copies: one full-length (protein-coding) and several truncated pseudogenes; these are a result of complex duplication events on chromosome 5q13[1][3][4]. No biological, disease, or therapeutic function is attributed to NAIPP3 itself; any such roles are associated with the functional NAIP gene. It is not a known therapeutic target, and its clinical or pharmacological significance is negligible[1][2][3][4]. **Key points:** - NAIPP3 is a **non-coding pseudogene** derived from the NAIP gene family[3][4]. - It does **not produce an active protein**, nor is it a therapeutic or pharmacological target. - The true biological and clinical relevance lies with the *functional* NAIP gene, not its pseudogene copies. - If the intention was to refer to the functional protein, the correct term is "NLR family apoptosis inhibitory protein" (abbreviation: NAIP or BIRC1)[1][2][3][4]. **Summary of possible issues:** - **is_incorrect:** true. The query refers to a pseudogene, not a protein or functional target. - **is_target:** false. Pseudogenes like NAIPP3 are not therapeutic targets. - **Use functional "NAIP" for target-based structured data**—not NAIPP3.

Other names
NAIP pseudogene 3NAIPP3NLR family apoptosis inhibitory protein pseudogene

Beyond the preview

Go deeper on NLR family apoptosis inhibitory protein pseudogene 3 (NAIPP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLR family apoptosis inhibitory protein pseudogene 3 (NAIPP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call